Funding

Dr. Bright has received several research grants as principal investigator:

  • RG 3069A2/1, National Multiple Sclerosis Society): IL-3 receptor activation of microglia in CNS demyelination
  • PP0855, National Multiple Sclerosis Society: Gene expression associated with oligodendrocyte differentiation from stem cell in mice.
  • Vanderbilt University, CNRU Pilot/Feasibility grant: Vitamin D regulation of IL-12 in CNS demyelination.
  • Vanderbilt University, A.B Hancock Jr. Memorial Laboratory for Cancer Research: Treatment of Experimental Allergic Encephalomyelitis by COX-2 Inhibitors.
  • 1R01 NS 42257-01A2, National Institutes of Health: PPAR? regulation of IL-12 in CNS demyelination.
  • 3R01 NS 42257-01A2S1, National Institutes of Health - Supplemental: PPAR? regulation of IL-12 in CNS demyelination.
  • 1 R21 CA106207-01, National Institutes of Health: Curcumin inhibition of growth signaling in leukemia.
  • S-2006-01, Showalter Foundation: Curcumin regulation of Myocarditis.